Exhibition
Thailand Boosts Online Mega-Events Reaching Global Fan Base amidst COVID-19 Pandemic
BANGKOK, June 2, 2020 /PRNewswire/ -- Despite the COVID-19 pandemic, Thailand
has boosted its mega-events industry, with the completion of online events
derived from successful festivals.
2020-06-02 14:24
2795
Westwin Joins Webinar Offering Response Strategies for Post-COVID-19 Business Challenges
SHANGHAI, June 1, 2020 /PRNewswire/ -- Westwin, a leading tech-driven cross-border marketing company, was invited to join a webinar recently to share insights about consumer behaviors in the post-COVID-19 world. Produced by BXP & VMSD Magazine, the online eventaimed to help global brands quickly ...
2020-06-02 11:57
1618
Made-in-China.com to hold online synchronous event for the 127th Canton Fair
NANJING, China, June 1, 2020 /PRNewswire/ -- With the development of digital technology, there is a tendency for traditional business going online. Also, the COVID-19 pandemic is still spreading around the world. Therefore, in order to keep pace with the times and in response to the many nations'...
2020-06-02 09:48
1818
DevOps Enterprise Summit London Unveils Virtual Program that Promises to Engage Attendees Through a Dynamic Learning Experience for the DevOps Community
IT Revolution Structuring its Virtual Conference to Maximize a Dynamic, Engaging Attendee Experience Through Experience Reports from Top Industry Domain Experts, Q&As with Speakers, and Opportunities for Attendee Interactions PORTLAND, Oregon, June 1, 2020 /PRNewswire/ -- In today's COVID-19 pand...
2020-06-01 16:03
1645
Huawei Global Analysts Summit: Rethink The Seamless AI Experience With Glocal HMS Ecosystem
SHENZHEN, China, June 1, 2020 /PRNewswire/ -- At the 2020 Huawei Analyst Summit held inShenzhen, Huawei Consumer Business Group (CBG) met with analysts to discuss the latest industry trends, innovative technologies, and ecosystem development. The theme of this year's summit was "Seamless AI Life"...
2020-06-01 11:00
3640
V Connect Launches Asia Artificial Intelligence Virtual Summit 2020
KUALA LUMPUR, Malaysia, June 1, 2020 /PRNewswire/ -- V Connect, the main
organiser ofAsia Artificial Intelligence Virtual Summit 2020
2020-06-01 11:00
3124
Supermicro CEO Computex Keynote - 5G Infrastructure Innovation
Supermicro CEO Charles Liang Delivers Keynote Address at COMPUTEXOnline TAIPEI, Taiwan, June 1, 2020 /PRNewswire/ -- COMPUTEXOnline -- Super Micro Computer, Inc. (Nasdaq: SMCI), a global leader in enterprise computing, storage, networking solutions and green computing technology, today announced ...
2020-06-01 10:00
2898
Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival Signal
SYDNEY, June 1, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share a poster presentation of interim data from the ongoing phase II study of paxalisib (formerly GDC-0084) in glioblastoma, the most comm...
2020-06-01 08:45
4930
Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type)
SUZHOU, China, May 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announced ...
2020-06-01 07:30
1664
Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin's Lymphoma
SUZHOU, China, May 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines, jointly announced with Eli Lilly and Company (Lilly) (NYSE: LLY) the research results of TY...
2020-06-01 07:30
1743
Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
SUZHOU, China, May 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines, jointly announced with Eli Lilly and Company (Lilly) (NYSE: LLY) the results of TYVYT® (sin...
2020-06-01 07:30
2449
Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type)
SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announced ...
2020-06-01 07:30
4837
Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin's Lymphoma
SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines, jointly announced with Eli Lilly and Company (Lilly) (NYSE: LLY) the research results of TY...
2020-06-01 07:30
4826
Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines, jointly announced with Eli Lilly and Company (Lilly) (NYSE: LLY) the results of TYVYT® (sin...
2020-06-01 07:30
5100
Innovent Biologics Announced the Results of the Phase 1b Clinical Study of TYVYT® (Sintilimab Injection) in Combination with IBI305 (Bevacizumab Biosimilar) in the Treatment of Advanced Hepatocellular Carcinoma
SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announce...
2020-06-01 07:30
4763
(ASCO2020) Ascentage Pharma Presents Latest Clinical Data of Apoptosis Targeting Drug Candidates, Showing Promising Clinical Effects with Combination Therapies
SUZHOU, China and ROCKVILLE, Md., May 31, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company presented fo...
2020-05-31 20:00
2058
Suntech Awarded a Third Year Top Performer in DNV-GL/PVEL 2020 PV Module Reliability Scorecard
WUXI, China, May 31, 2020 /PRNewswire/ -- On May 28, 2020, the 'Top Performer of DNV-GL/PVEL 2020 PV Module Reliability Scorecard' webinar, jointly hosted by DNVL GL and PV Evolution Labs (PVEL), was successfully held. At this show, Suntech mono PERC half-cell modules were granted the title of "T...
2020-05-31 13:00
2384
Guardant360 test results may provide prognostic information beyond the detection of actionable biomarkers for ALK-rearranged NSCLC patients
SINGAPORE, May 30, 2020 /PRNewswire/ -- According to the data presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on29 May 2020, researchers at Samsung Medical Center inSeoul, Korea, have found useful prognostic information beyond actionable biomarkers when the Guardant36...
2020-05-30 19:00
3151
Gracell Announces Two Presentations at the Annual Meeting of American Society of Clinical Oncology (ASCO)
SUZHOU, China and SHANGHAI, May 29, 2020 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell and gene therapy company, today announced that two presentations were accepted at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program. ...
2020-05-29 20:00
2010
I-Mab Announces Upcoming Participation at June Conferences
SHANGHAI and GAITHERSBURG, Md., May 29, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical ...
2020-05-29 20:00
5966
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 274 media titles]
2024-04-24 17:09
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
7889
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
6989
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
2024-04-24 13:00
4283
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2919